The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis
- PMID: 21544063
- DOI: 10.1038/ki.2011.121
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis
Abstract
The unchecked overproduction of reactive oxygen and nitrogen species by inflammatory cells can cause tissue damage, intensify inflammation, promote apoptosis, and accelerate the progression of immune-mediated glomerulonephritis (GN). Here we tested whether the anti-inflammatory and antioxidant properties of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) favorably affect the development of immune-mediated GN. Pretreatment of 129/svJ mice with EGCG from 2 days before to 2 weeks after the induction of GN led to reduced proteinuria and serum creatinine, and marked improvement in renal histology when compared with vehicle-pretreated diseased mice. This pretreatment reduced oxidative stress, and normalized osteopontin, p65/nuclear factor-κB, inducible nitric oxide synthase, nitric oxide metabolites, p-Akt, phosphorylated extracellular signal-regulated kinases 1 and 2, p47phox, and myeloperoxidase, all of which were elevated in vehicle-pretreated diseased mice. Levels of glutathione peroxidase and peroxisome proliferator-activated receptor-γ (PPARγ), both reduced in the vehicle-pretreated diseased mice, were normalized. This renoprotective effect was reversed by concomitant administration of the PPARγ antagonist GW9662 throughout the EGCG pretreatment period. Importantly, mortality and renal dysfunction were significantly attenuated even when the polyphenol treatment was initiated 1 week after the onset of GN. Thus, EGCG reversed the progression of immune-mediated GN in mice by targeting redox and inflammatory pathways.
Comment in
-
Glomerulonephritis therapy: is there a role for green tea?Kidney Int. 2011 Sep;80(6):563-4. doi: 10.1038/ki.2011.173. Kidney Int. 2011. PMID: 21878951
Similar articles
-
Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.PLoS One. 2015 Apr 15;10(4):e0124775. doi: 10.1371/journal.pone.0124775. eCollection 2015. PLoS One. 2015. PMID: 25875356 Free PMC article.
-
Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.PLoS One. 2015 Mar 18;10(3):e0119543. doi: 10.1371/journal.pone.0119543. eCollection 2015. PLoS One. 2015. PMID: 25785827 Free PMC article.
-
Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.Basic Clin Pharmacol Toxicol. 2015 Sep;117(3):164-72. doi: 10.1111/bcpt.12383. Epub 2015 Feb 19. Basic Clin Pharmacol Toxicol. 2015. PMID: 25625183
-
Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG.Food Chem Toxicol. 2008 Apr;46(4):1271-8. doi: 10.1016/j.fct.2007.10.006. Epub 2007 Oct 17. Food Chem Toxicol. 2008. PMID: 18082923 Review.
-
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.Photochem Photobiol. 1999 Feb;69(2):148-53. Photochem Photobiol. 1999. PMID: 10048310 Review.
Cited by
-
Effect of Tea Polyphenols, α-Lipoic Acid and Their Joint Use on the Antioxidant and Lipid Metabolism Performance of Hybrid Grouper (♀Epinephelus fuscoguttatus × ♂E. lanceolatu) Fed with High-Lipid Diets.Aquac Nutr. 2023 Oct 30;2023:1393994. doi: 10.1155/2023/1393994. eCollection 2023. Aquac Nutr. 2023. PMID: 37936718 Free PMC article.
-
PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs.PPAR Res. 2023 Jun 8;2023:4481354. doi: 10.1155/2023/4481354. eCollection 2023. PPAR Res. 2023. PMID: 37334066 Free PMC article.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Flavonoids in Treatment of Chronic Kidney Disease.Molecules. 2022 Apr 6;27(7):2365. doi: 10.3390/molecules27072365. Molecules. 2022. PMID: 35408760 Free PMC article. Review.
-
Heightened Crescentic Glomerulonephritis in Immune Challenged 129sv Mice Is TGF-β/Smad3 Dependent.Int J Mol Sci. 2021 Feb 19;22(4):2059. doi: 10.3390/ijms22042059. Int J Mol Sci. 2021. PMID: 33669690 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials